false
Category
Author
Search for Articles
Trending Keywords
Category
Author
Search
Category
Author
Search
醫療健康

What are targeted drugs? Can they treat cancer? Learn about their principles, types, and effects.

2025-04-11 5min read
標靶藥

In recent years, cancer treatment technologies have continuously advanced, with targeted therapy becoming a significant approach. Unlike traditional chemotherapy, targeted therapy precisely targets specific substances in cancer cells for "attack", minimising the impact on normal cells. This makes the treatment more effective and brings greater hope to cancer patients. In this article, 10Life will provide an in-depth analysis of the principles, types, effects, and side effects of targeted drugs, helping everyone gain a clearer understanding of cancer targeted therapies.

What is Targeted Therapy?

Targeted Therapy is a treatment method that focuses on specific molecules in cancer cells. Compared to traditional chemotherapy, targeted drugs can more precisely inhibit and destroy cancer cells while having a lesser impact on normal cells, resulting in relatively milder side effects.

Targeted drugs are mainly divided into small molecule drugs and monoclonal antibodies. Small molecule drugs can penetrate inside cancer cells, interfering with their growth signals or blocking specific molecules, thereby inhibiting cancer cell activity. Monoclonal antibodies, on the other hand, are larger immune system proteins that cannot enter cells but can mark cancer cells with specific proteins. By blocking growth signals or guiding the immune system to attack cancer cells, they prevent cancer cells from continuing to divide and grow.

The administration of targeted drugs includes oral intake, intravenous injection, or subcutaneous injection. However, not all cancer patients are suitable for this treatment. Doctors typically conduct genetic testing or biopsies to confirm whether the cancer cells have usable receptors (targets) before deciding if this treatment method is appropriate.

Principles of Targeted Therapy

Cancer cells differ from normal cells due to genetic mutations that result in a large number of abnormal receptors, continuously receiving growth signals, causing uncontrolled division and the formation of tumours. In addition to genetic mutations, certain abnormal proteins also send and receive signals, further promoting cancer cell growth. Targeted therapies are designed to address these receptors (targets) by locking onto specific proteins or genetic mutations, interfering with the growth mechanisms of cancer cells, preventing their proliferation, and ultimately leading to their death.

Common Types of Targeted Therapy Drugs

Targeted drugs can be divided into different types, each designed to address specific characteristics of cancer cells.

Signal Transduction Inhibitors

The growth of cancer cells relies on signal transmission. These drugs block the signalling pathways within cancer cells, preventing them from dividing further.

Angiogenesis Inhibitors

Tumours require blood vessels to supply nutrients for growth. Angiogenesis inhibitors prevent the formation of new blood vessels in tumours, depriving them of nutrients and causing them to shrink over time.

Apoptosis-Inducing Drugs

Healthy cells naturally die when they age or become damaged (a process called apoptosis), but cancer cells often evade this mechanism. These drugs activate the apoptosis mechanism in cancer cells, causing them to self-destruct.

Immunotherapy Drugs

Some cancer cells can hide themselves to avoid detection by the immune system. Certain immune-targeted drugs help immune cells recognise and attack cancer cells.

Toxin-Conjugated Monoclonal Antibodies

These drugs deliver toxins or radioactive substances directly into cancer cells, damaging or killing them without affecting normal cells.

Which cancers can targeted drugs treat?

Targeted therapy has been widely used in the treatment of various cancers, particularly for tumours with specific genetic mutations or abnormal proteins. Currently, cancers that can be treated with targeted therapy include:

  • Lung cancer
  • Breast cancer
  • Colorectal cancer
  • Liver cancer
  • Kidney cancer
  • Prostate cancer
  • Blood cancers (such as leukaemia, multiple myeloma, lymphoma)
  • Brain cancer (such as glioblastoma)
  • Digestive system cancers (such as oesophageal cancer, gastric cancer, pancreatic cancer, bile duct cancer)
  • Head and neck cancers (such as nasopharyngeal cancer, laryngeal cancer, oral cancer)
  • Skin cancer (such as melanoma)
  • Thyroid cancer
  • Bladder cancer

The targeted drugs used vary depending on the type of cancer. Doctors will assess whether targeted therapy is suitable based on genetic testing results and develop an appropriate treatment plan.

Who is suitable for targeted drug therapy?

Targeted therapy is not suitable for all cancer patients, and doctors will evaluate based on multiple factors. Firstly, different types of cancer have distinct genetic mutations, and it is necessary to confirm whether the cancer cells possess targetable markers. To ensure that targeted drugs are appropriate for individual patients, doctors typically conduct genetic testing to verify if the cancer cells have suitable targets. Secondly, the extent of tumour spread is considered; targeted therapy is more commonly used for cancers that have spread or are inoperable, to suppress tumour growth. Additionally, if a patient responds poorly to chemotherapy or radiotherapy, the doctor may consider switching to targeted therapy or combining it with other treatment methods. 

Targeted drugs can be used alone or in combination with chemotherapy, radiotherapy, or immunotherapy to enhance the overall treatment effectiveness.

The side effects of targeted therapy vary from person to person and are mainly influenced by the type of drug and individual constitution. Below are some common side effects:

  • Gastrointestinal discomfort: nausea, vomiting, diarrhoea, and some patients may experience a loss of appetite.
  • Skin issues: rashes, dryness, acne-like rashes, nail changes, and hair depigmentation.
  • High blood pressure: some targeted drugs affect vascular function, leading to elevated blood pressure.
  • Delayed wound healing: affects the clotting mechanism, prolonging wound recovery time.
  • Immune system effects: may trigger autoimmune reactions, impacting organs such as the lungs and liver.
  • Liver function abnormalities: elevated liver enzymes and increased risk of hepatitis.
  • Cardiac effects: may impact heart function, increasing the risk of arrhythmias or heart failure.
  • Gastrointestinal complications: in rare cases, may lead to gastrointestinal perforation.

Doctors will adjust the drug dosage based on the patient's condition and provide supportive treatments to alleviate side effects. Most side effects will gradually subside after the treatment ends, but since some cancer-targeted drugs are relatively new, there may also be potential longer-term effects. Therefore, patients should undergo regular check-ups to ensure the safety of the treatment.

Reference Costs for Targeted Therapy Drugs

The price of targeted therapy drugs is usually influenced by various factors, including the patient's weight, dosage requirements, treatment frequency, and the type of drug. Below are the targeted therapy drugs for different types of cancer and their monthly reference costs:

CancerCommonly Used Targeted Therapy DrugsMonthly Reference Cost (HKD)

Breast Cancer

Trastuzumab, Lapatinib, Bevacizumab, Everolimus, Pertuzumab and its Antibody-Drug Conjugates

Approx. $20,000 - $80,000

Colorectal Cancer

Pembrolizumab, Cetuximab, Bevacizumab, Aflibercept, Regorafenib

Approx. $20,000 - $140,000

Lung Cancer

Gefitinib, Afatinib, Crizotinib, Bevacizumab, Erlotinib

Approx. $50,000 - $135,000

Liver Cancer

Sorafenib

Approx. $150,000

Head and Neck Cancer

Cetuximab

Approx. $15,000

Gastric Cancer

Trastuzumab

Approx. $30,000

Kidney Cancer

Temsirolimus, Everolimus, Pazopanib, Axitinib, Bevacizumab, Sunitinib, Sorafenib

Approx. $20,000 - $40,000

Ovarian Epithelial/Fallopian Tube/Primary Peritoneal Cancer

Bevacizumab

Approx. $30,000

Pancreatic Cancer

Sunitinib, Everolimus, Erlotinib

Approx. $27,000 - $120,000

Brain Cancer

Everolimus, Bevacizumab

Approx. $20,000 - $70,000

The above costs are for reference only. Actual costs may vary depending on individual patient conditions. For more accurate information, please consult a doctor if necessary.

Buy critical illness insurance early to plan ahead and protect your health

In Hong Kong, cancer patients facing financial difficulties can apply for the Samaritan Fund and the Community Care Fund Medical Assistance Programmes to alleviate the high costs of targeted therapy. However, even with subsidies, medical expenses remain substantial, and they do not cover daily living expenses or rehabilitation costs. Purchasing critical illness insurance early can provide financial support during illness, reducing economic burdens and allowing peace of mind during treatment. Critical illness insurance involves specialised knowledge that the general public may not fully understand. When purchasing a policy, you are welcome to consult10Life licensed insurance advisors for professional advice to prepare for the future.

Further Reading

【Breast Cancer】A Comprehensive Guide to Symptoms, Types, Treatments, and Prevention Methods
【Critical Illness Insurance Comparison 2025】Which Whole Life Critical Illness Insurance is the Best? Key Insights into 5-Star Policies
What is the Waiting Period for Critical Illness Insurance? Key Considerations When Purchasing Critical Illness Insurance
【Prostate Cancer】Understanding Symptoms, Causes, Treatments, and Prevention Methods for Prostate Cancer

Sources:

Last updated: 11 April 2025

This English version of this article has been generated by machine translation powered by AI. It is provided solely for reference purposes. In the event of any discrepancy or inconsistency between this translation and the original Chinese version, the Chinese version shall prevail.

10Life 編輯團隊

團隊成員由一群資料搜集員組成,主力保險相關資訊研究。

10Life 編輯團隊

團隊成員由一群資料搜集員組成,主力保險相關資訊研究。

Disclaimer

10Life 产品比较和 10Life 保险评分由获保监局授权持牌保险经纪公司 10Life Financial Limited(保监局牌照号码为FB1526)营运。10Life 产品比较和 10Life 保险评分是根据产品数据、事实陈述以及数据,并以一般消费者作为对象,从而作出数学运算,并不受与保险公司任何形式之合作或所获得之费用所影响。

10Life平台上之任何信息(「10Life信息」),包括但不限于产品比较、产品评分、网志文章等,旨在向香港特别行政区(「香港」)境内人士发布,所有信息及服务对象为于身处香港境内人士,仅供一般教育及参考用途。10Life信息无意,也不应被视为对任何保险、金融或投资产品进行受监管建议或专业建议、推荐、批准、认可、邀请或招揽。10Life信息并没有考虑阁下之个人需要,阅览有关数据也不应被视为正在进行个人合适性评估,且不足以构成任何购买保险产品决定的依据。购买任何保险产品或进行有关保险决定前,阁下应以保险公司提供的数据为准,自行进行研究,及/或寻求持牌保险中介人的独立及专业意见。10Life信息是以最大努力从不同渠道收集、验证、更新而成。10Life集团及其附属公司、关连人士、代理、董事、职员、员工将不会就有关资料引致的责任、索偿或损失负上任何责任,也概不保证或担保有关资料之准确性、完整性和适时性。

所显示保费数据尚未包括保险业监管局收取的保费征费,并均四舍五入至港元个位数。

如阁下对 10Life 产品比较和 10Life 保险评分有任何意见,欢迎电邮至 enquiries@10life.com

Whatsapp icon
Whatsapp icon
WeChat icon
WeChat icon
Enquiry icon Close icon
Back To Top
Whatsapp icon
Whatsapp icon
WhatsApp